National Comprehensive Cancer Network



NCCN Oncology Research Program (ORP)
NCCN Volasertib Research Grant Opportunity – Submit by October 30, 2014
NCCN ORP Recent News
NCCN ORP Affiliate Research Consortium
NCCN ORP Scientific Publications
NCCN ORP for Industry
NCCN ORP Investigator Steering Committee
NCCN ORP Testimonials
NCCN Clinical Trials at NCCN Member Institutions
Find NCCN ORP Funded Clinical Trials at NCCN Member Institutions
NCCN Informed Consent Language Database
NCCN Specialized Imaging Research Consortium™ (SIRC)
NCCN ORP Disclosure Policy
NCCN Collaboration with the National Business Group on Health
NCCN Health Information Technology Licensees

NCCN Research & Business Resources

Learn more about clinical trials at this NCCN Member Institution.

Adult Oncology Services

Treatment

Brain Tumor Program

The Brain Tumor Program is a multidisciplinary group dedicated to the care of patients with primary brain tumors, brain metastases, and neurological complications of cancer. It is the only multidisciplinary consortium providing comprehensive brain cancer care in southern New England and has gained regional and national recognition.

The physicians of the Brain Tumor Program offer a wide spectrum of advanced strategies for the diagnosis and treatment of brain cancer including microsurgical tumor removal, intraoperative neurophysiological monitoring, image-guided stereotactic techniques, 3D conformal radiotherapy, stereotactic radiosurgery (gamma knife), and novel, targeted chemotherapies. The program is comprised of the departments of Neurosurgery, Neurology, Medical Oncology, Therapeutic Radiology, Neuropathology, and Neuroradiology. A dedicated patient coordinator facilitates patient appointments and communication, coordinates services, and supports patients and their families.

Breast Center
The Breast Center at Smilow Cancer Hospital at Yale-New Haven provides coordinated, state-of-the-art care for patients with benign and malignant diseases of the breast.  For patients diagnosed with breast cancer, we offer dedicated care, innovative treatment options, and cutting edge research, coupled with the recognized excellence of a National Cancer Institute designated Comprehensive Cancer Center. A great deal of progress in the detection and treatment of breast cancer has been made in recent years, and our physicians are on the leading edge of finding even better solutions.  

Our Center is accredited by the National Accreditation Program for Breast Centers, and was the first National Cancer Institute Comprehensive Cancer Center in the Northeast to hold this designation.  Women with a diagnosis of breast cancer are cared for by a multidisciplinary team of physician specialists, including radiologists, breast surgeons, medical oncologists, radiation oncologists, pathologists, and plastic surgeons. 

At Smilow Cancer Hospital at Yale-New Haven, patients benefit from the expertise of a team approach to cancer care.   Our multidisciplinary team meets weekly in our Tumor Board Conference to review cases and provide patients with the optimal care plan, ideally suited to them.  Decisions are based on the most up-to-date research to ensure that all patients receive the best available breast cancer treatment.  In addition, nurses, social workers, physical therapists, psychologists and other health professionals are key members of the team, providing the necessary supportive care throughout the breast cancer journey.  Our goal is to ensure the highest standard of patient- and family-centered multidisciplinary care that takes care of the whole patient.  

Endocrine Cancers Program
The Endocrine Cancers Program offers evaluation, diagnosis and treatment of tumors of the thyroid, parathyroid, adrenal glands, pituitary gland, hypothalamus, and pancreas. It is one of the largest multidisciplinary endocrine cancer programs in the country and cares for over 1,000 patients each year. Our surgeons are internationally recognized for their minimally invasive techniques and their groundbreaking research in benign and malignant endocrine disorders. 

Thyroid cancer is the most common endocrine cancer. Thyroid nodules are common, and while more than 95 percent of thyroid tumors are not cancerous, there is a tremendous advantage to being evaluated and treated by experts in endocrine diseases. The preferred method for our physicians to evaluate a nodule is through a fine-needle aspiration biopsy. This procedure may be performed during a clinic visit. When cancer is suspected to be in a nodule, surgery is recommended.

Yale-New Haven Hospital's Endocrine Surgery program is accredited by the American College of Surgeons. The program serves as a respected training ground for the best and brightest general surgeons, and includes a fellowship in collaboration with the American Association of Endocrine Surgeons. Researchers participate in national and international clinical trials. 

Gastrointestinal Cancers Program
The multidisciplinary Gastrointestinal Cancers Program at Smilow Cancer Hospital provides all gastrointestinal cancer patients with a truly multidisciplinary approach to the treatment of their complex disease. Our physicians have special expertise in the treatment of cancers of the esophagus, stomach, liver, pancreas, colon, and rectum.

Using a comprehensive team approach, our oncologists collaborate with diagnostic and interventional radiologists, gastroenterologists, and pathologists to provide the most expert care available for cancer patients. Nationally accepted treatment plans are provided for patients who have recently been diagnosed with cancer; more individualized plans are carefully customized for patients who have not responded to prior therapies and clinical trials are often available for both situations. In one visit, patients will have encountered a team of physicians who will work together, combining their skills and knowledge to provide the highest quality of care. The result is a personal comprehensive treatment plan.

Gynecologic Oncology Program
Each gynecologic cancer is unique, with different signs and symptoms, different risk factors and different prevention strategies. All women are at risk for different types of gynecologic cancer, and risk increases with age. A woman who is experiencing abdominal or pelvic pain should see her doctor. Symptoms may be caused by something other than gynecologic cancer, but an evaluation by a physician is the only way to know for sure.

At Smilow Cancer Hospital, we treat precancerous changes of the vulva, vagina and cervix, including dysplasia and carcinomas in situ; premalignant changes of the endometrium, including adenomatous hyperplasias; vulvar cancer; vaginal cancer; cervical cancer; uterine cancer; fallopian tube cancer; ovarian cancer and gestational trophoblastic disease; and soft-tissue tumors of the pelvis.
Our physicians are board-certified in obstetrics and gynecology and in the subspecialty of gynecologic oncology, which brings together surgery, chemotherapy and radiation oncology.  All therapeutic decisions are made by a multidisciplinary panel of experts in the field of gynecologic malignancy diagnosis and management.

Head and Neck Cancers Program
The Head and Neck Cancers Program at Smilow Cancer Hospital is composed of highly dedicated physicians and surgeons joined by a skilled team of rehabilitation specialists in speech, swallowing, and hearing restoration. All physicians are board certified and fellowship trained. A collaborative approach to care offers the most effective of treatment options for diseases affecting the ear, sinuses, larynx, and pharynx, while emphasizing the organ-sparing mission of Yale Cancer Center.

The team includes a multidisciplinary group of healthcare professionals, including head and neck surgeons, radiation oncologists, medical oncologists, physical and speech therapists, nutritionists, advanced practice nurses and social workers, as well as patient advocates. This team approach gives newly diagnosed patients a carefully determined treatment plan focused on providing the most comprehensive, effective care possible.

Hematology Program
The Hematology Program at Smilow Cancer Hospital offers the most comprehensive services for the diagnosis and treatment of blood cancers in the region. Our services are designed to meet each patient’s physical, emotional, and psychological needs. Physicians within the program are organized into a multispecialty team that discusses the treatment plans for patients until consensus is reached on the best management course for each individual patient.

Causes of these cancers remain unknown but advances in treatment, some of which came from research at Yale Cancer Center, are increasing survival rates. Our researchers continue to work on current promising therapies and are able to offer treatment for all phases and stages of lymphoma, leukemia, and myeloma.

Melanoma Program
The Melanoma Program at Smilow Cancer Hospital is a multidisciplinary team developed over 25 years ago to discover new treatments and provide state-of-the-art treatment for patients with melanoma.  In order to achieve its objectives, the Melanoma Program brings together scientists, specialists in melanoma surgery, medical oncologists devoted to melanoma treatment, dermatologists, pathologists, dermatopathologists, radiologists, geneticists, and psychotherapists.  Cliinical trials for patients with advanced melanoma have led to promising treatment findings using immunotherapy and combinations of targeted therapies at Yale in recent years.

Clinical care of melanoma patients at Smilow Cancer Hospital is a coordinated effort of the Melanoma team. A tumor board conference is held each week to discuss clinical history, physical exam findings, surgical procedures, x-ray studies, and pathology slides, and optimal approaches to treatment for each patient are proposed and discussed at length.

Prostate and Urologic Cancers Program
The Prostate and Urologic Cancers Program at Smilow Cancer Hospital offers patients easy access to specialized care for these cancers. As a multispecialty program it is dedicated to providing cutting-edge technology for the evaluation, diagnosis, and treatment of prostate cancer and other urologic cancers (bladder, kidney and testicular cancer). Specialties involved include medical oncology, radiation oncology, surgical oncology, pathology, and diagnostic imaging.

Physicians meet regularly to discuss every patient's care and to develop a comprehensive treatment plan unique for each patient, in consultation with the patient's referring physician. Not only does the team provide a complete range of standard treatments, but also available are medical and surgical approaches not found elsewhere in Connecticut. Treatment modalities include: non-invasive surgical techniques with laparoscopic surgery, precision guided intensity modulated radiotherapy (IMRT), combined modality approaches with chemotherapy and radiotherapy, and novel experimental therapies.

Sarcoma Program
The Sarcoma Program at Smilow Cancer Hospital is a multidisciplinary team of physicians specialized in the diagnosis, treatment, and care of patients with both soft tissue sarcoma and sarcoma of the bone.  Diagnostic tools at Smilow Cancer Hospital used to diagnose sarcomas include basic X-ray; CT scanning, excellent at seeing both bone and soft tissues; MRI, which has the ability to "view" the tissue in and around bone with exquisite detail; and PET scanning that is able to look at biological activity at the cellular level.

The Program includes orthopedic physicians, dermatologists, diagnostic radiologists, medical oncologists, surgical oncologists, radiation oncologists, and pathologists, all with specific expertise in the treatment and care of patients with sarcoma.

Thoracic Oncology Program
The Thoracic Oncology Program is a multidisciplinary program dedicated to providing cutting-edge evaluation and treatment to patients with thoracic malignancies in an efficient and coordinated manner.  Through the Thoracic Oncology Program, patients have access to nationally recognized expert clinicians, who provide an organized, collaborative approach to cancer care, and access to the latest technologies and treatments. Patients also benefit from newly available cancer therapies resulting from scientific insights gained in Yale laboratories and those of other comprehensive cancer centers in the United States.

The program coordinates and integrates the diagnosis, evaluation, and treatment of patients with a thoracic malignancy, including lung cancer, esophageal cancer, thymoma, or chest wall tumors.   Specialties involved include medical oncology, radiation oncology, thoracic surgery, pulmonary medicine, digestive diseases, pathology, diagnostic imaging, and nursing.

 

Smilow Cancer Hospital Clinical Programs

Brain Tumor
(203) 785-7284

Breast Center
(203) 200-2328

Endocrine Cancers
(203) 200-3636

Gastrointestinal Cancers
(203) 200-4422

Gynecologic Oncology
(203) 200-4176

Head & Neck Cancers
(203) 200-4622

Hematology
(203) 200-4363

Melanoma
(203) 200-6622

Pediatric Hematology & Oncology
(203) 200-785-4081

Prostate & Urologic Cancers
(203) 200-4822

Sarcoma
(203) 737-5660

Thoracic Oncology
(203) 200-5864

 

Smilow Cancer Hospital Care Centers

Derby
(203) 734-1664

Guilford
(203) 453-9192

New Haven
(203) 867-5420

North Haven
(203) 407-8002

Orange
(203) 795-1664

Sharon
(860) 364-0531

Torrington
(860) 482-5384

Waterbury
(203) 755-6311

 

Support Groups

Brain Tumor
Early Stage Breast Cancer
Metastatic Breast Cancer
Breast Cancer – Shoreline Medical Center
Gastrointestinal Cancers
Head and Neck Cancers
Kidney Cancer
Lung Cancer
Metastatic Melanoma
Multiple Myeloma
Patient and Family Support – Saint Raphael Campus
Prostate Cancer
Prostate Cancer – Saint Raphael Campus
Radiation Support for Patients and Families
Stem Cell Transplant
Shoreline Patient and Family
Young Adult Cancer Support

http://medicine.yale.edu/cancer/patient/support/groups.aspx